It May Be Time To Waive Patients’ Costs for Coronavirus Treatment
In his Axios column, Drew Altman looks at the numbers for COVID-19 treatment, and why it may soon be necessary for Congress to waive out-of-pocket costs for treatment.

Related Content

Exit mobile version